Please login to the form below

Not currently logged in
Email:
Password:

inVentiv Health wins Pfizer account

Will be tasked with managing the pharma firm’s global clinical services

inVentiv HealthUS pharmaceutical services organisation inVentiv Health has been named by Pfizer as its preferred provider for global clinical services.

The company will oversee Pfizer's sourcing strategy for the clinical operations of all its worldwide business until June 2019, at which point Pfizer may extend the deal for a further two years.

President of the clinical division at inVentiv Health Dr Michael McKelvy, said: "Complex science and challenging marketplace dynamics are driving the need for new, accelerated approaches to clinical development."

He added: "This agreement is an indication that our leading full-service clinical offerings are value-enhancing and scalable. We designed this approach to deliver patient-centric outcomes in an increasingly competitive environment."

As a result of winning Pfizer's clinical operations account, inVentiv Health expanded its clinical operations, with a focus on oncology, pain, neuroscience and respiratory therapeutic areas as well as data and technology-driven efficiency measures.

Gregory Skalicky, chief commercial officer of inVentiv Health's clinical division, said: "The expansion of our relationship under this new preferred provider status will allow us to continue to seamlessly orchestrate our full suite of clinical solutions.

"We're committed to realising improved efficiencies in support of Pfizer's clinical development activities."

Article by
Rebecca Clifford

29th June 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics